SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001140361-23-045416
Filing Date
2023-09-27
Accepted
2023-09-27 08:25:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A ef20011374_sc14d9a.htm SC 14D9/A 21116
  Complete submission text file 0001140361-23-045416.txt   22935
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88971 | Film No.: 231281886
SIC: 2834 Pharmaceutical Preparations